PL1799204T3 - Kompozycja zawierająca kwasy tłuszczowe omega-3 i omega-6 - Google Patents

Kompozycja zawierająca kwasy tłuszczowe omega-3 i omega-6

Info

Publication number
PL1799204T3
PL1799204T3 PL05801288T PL05801288T PL1799204T3 PL 1799204 T3 PL1799204 T3 PL 1799204T3 PL 05801288 T PL05801288 T PL 05801288T PL 05801288 T PL05801288 T PL 05801288T PL 1799204 T3 PL1799204 T3 PL 1799204T3
Authority
PL
Poland
Prior art keywords
omega
fatty acids
composition containing
fatty acid
composition
Prior art date
Application number
PL05801288T
Other languages
English (en)
Inventor
Gudrun Claus-Herz
Günther Bellmann
Original Assignee
Dr Gerhard Mann Chem Pharm Fabrik Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Gerhard Mann Chem Pharm Fabrik Gmbh filed Critical Dr Gerhard Mann Chem Pharm Fabrik Gmbh
Publication of PL1799204T3 publication Critical patent/PL1799204T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pediatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL05801288T 2004-10-13 2005-10-11 Kompozycja zawierająca kwasy tłuszczowe omega-3 i omega-6 PL1799204T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE202004015931U DE202004015931U1 (de) 2004-10-13 2004-10-13 Omega-3-Fettsäuren und Omega-6-Fettsäuren enthaltende Zusammensetzung
EP05801288A EP1799204B1 (de) 2004-10-13 2005-10-11 Omega-3-fettsäuren und omega-6-fettsäuren enthaltende zusammensetzung
PCT/EP2005/055168 WO2006040324A1 (de) 2004-10-13 2005-10-11 Omega-3-fettsäuren und omega-6-fettsäuren enthaltende zusammensetzung

Publications (1)

Publication Number Publication Date
PL1799204T3 true PL1799204T3 (pl) 2010-02-26

Family

ID=34042499

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05801288T PL1799204T3 (pl) 2004-10-13 2005-10-11 Kompozycja zawierająca kwasy tłuszczowe omega-3 i omega-6

Country Status (11)

Country Link
US (1) US20080260859A1 (pl)
EP (1) EP1799204B1 (pl)
CN (1) CN101039665A (pl)
AT (1) ATE443515T1 (pl)
CA (1) CA2582934C (pl)
DE (2) DE202004015931U1 (pl)
ES (1) ES2332102T3 (pl)
PL (1) PL1799204T3 (pl)
RU (1) RU2381025C2 (pl)
UA (1) UA88030C2 (pl)
WO (1) WO2006040324A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202004015931U1 (de) * 2004-10-13 2005-01-05 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Omega-3-Fettsäuren und Omega-6-Fettsäuren enthaltende Zusammensetzung
CA2694054C (en) * 2007-07-25 2015-11-17 Epax As Omega-3 fatty acid fortified composition
US20090264520A1 (en) * 2008-04-21 2009-10-22 Asha Lipid Sciences, Inc. Lipid-containing compositions and methods of use thereof
WO2011060492A1 (en) * 2009-11-18 2011-05-26 The University Of Sydney Combination for treating metabolic disorders
WO2012067224A1 (ja) * 2010-11-19 2012-05-24 日本水産株式会社 角膜上皮障害及び/又は結膜上皮障害の治療又は予防剤
US10709680B2 (en) 2011-07-18 2020-07-14 Physicians Recommended Nutriceuticals, Llc Methods for treating dry eye
US9115078B2 (en) * 2011-07-18 2015-08-25 Physicians Recommended Nutriceuticals, Llc Compositions for improving the quality of the meibum composition of inflamed or dysfunctional meibomian glands
US9381183B2 (en) 2012-07-18 2016-07-05 Physicians Recommended Nutriceuticals, Llc Methods for improving the quality of the meibum composition of meibomian glands
US20210121430A1 (en) 2011-07-18 2021-04-29 Prn Physician Recommended Nutriceuticals, Llc Omega-3 fatty acid supplementation for use in treating dry eye
WO2013033618A1 (en) * 2011-09-02 2013-03-07 Arctic Nutrition As Lipid compositions with high dha content
NL2010550C2 (en) * 2012-11-30 2014-06-04 Klaas Alouis Riepma An intranasal pharmaceutical composition containing vitamin b12.
US10183044B2 (en) 2015-05-15 2019-01-22 P Tech, Llc Systems and methods for thrombosis prevention

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1263270A (en) * 1987-08-19 1989-11-28 Bruce J. Holub Animal feed supplement
EP0937408B1 (fr) * 1993-08-20 2004-02-11 Societe Des Produits Nestle S.A. Produit laitier comprenant une composition lipidique nutritionnelle
CA2210856A1 (en) * 1995-01-18 1996-07-25 Taisho Pharmaceutical Co., Ltd. Dermatitis-curing agent
US6428832B2 (en) * 1996-03-26 2002-08-06 Dsm N.V. Late addition of PUFA in infant formula preparation process
US6340705B1 (en) * 1999-09-10 2002-01-22 Monsanto Technology, Llc Use of α-linolenic acid metabolites for treatment or prevention of cancer
US7208180B2 (en) * 2000-05-08 2007-04-24 N.V. Nutricia Method and preparation for the preventing and/or treating vascular disorders and secondary disorders associated therewith
DE10057290B4 (de) * 2000-11-17 2004-01-08 Fresenius Kabi Deutschland Gmbh Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
US6506412B2 (en) * 2000-11-29 2003-01-14 Sciencebased Health Treatment of dry eye syndrome
DE10109798A1 (de) * 2001-03-01 2002-09-12 Aventis Pharma Gmbh Gesundheitsfördernde Zusammensetzung von Verbindungen
US20040048926A1 (en) * 2002-03-15 2004-03-11 Hoffman Dennis Robert Use of docosahexaenoic acid and arachidonic acid to enhance the visual development of term infants breast-fed up to the age of six months
EP1587377A2 (en) * 2003-01-31 2005-10-26 The Procter & Gamble Company Means for improving the appearance of mammalian keratinous tissue
JP2004357508A (ja) * 2003-05-30 2004-12-24 Fancl Corp ペット用サプリメント
FR2860976B1 (fr) * 2003-10-20 2006-02-10 Ravi Shrivastava Nouvelles compositions synergiques pour ameliorer la biodisponibilite et l'efficacite des acides gras polyinsatures pour le traitement des troubles du fonctionnement cerebral.
DE202004015931U1 (de) * 2004-10-13 2005-01-05 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Omega-3-Fettsäuren und Omega-6-Fettsäuren enthaltende Zusammensetzung

Also Published As

Publication number Publication date
WO2006040324A1 (de) 2006-04-20
CN101039665A (zh) 2007-09-19
EP1799204A1 (de) 2007-06-27
CA2582934C (en) 2012-12-04
EP1799204B1 (de) 2009-09-23
DE202004015931U1 (de) 2005-01-05
US20080260859A1 (en) 2008-10-23
DE502005008202D1 (de) 2009-11-05
ES2332102T3 (es) 2010-01-26
UA88030C2 (ru) 2009-09-10
RU2007117803A (ru) 2008-11-20
ATE443515T1 (de) 2009-10-15
RU2381025C2 (ru) 2010-02-10
CA2582934A1 (en) 2006-04-20

Similar Documents

Publication Publication Date Title
GB2459809A (en) Fatty acid formulations and methods of use thereof
EA200700240A1 (ru) Композиция, содержащая статины и омега - 3 жирные кислоты
Salem Jr et al. Losses of arachidonic acid in rat liver after alcohol inhalation
TW200631597A (en) External use preparation and adhesive preparation thereof
FR2955459B1 (fr) Composition huileuse riche en monoglycerides de dha
IL210233A (en) Formulation of omega-3 fatty acid containing epa and dha and no other active ingredients other than omega-3 fatty acids
BRPI0416403A (pt) composição de óleo enriquecida em diglicerìdeo com ácido linoléico conjugado
WO2006127069A3 (en) A delivery system for active components as part of an edible composition including a ratio of encapsulating material and active component
NZ600167A (en) Concentrated therapeutic phospholipid compositions
EA200801602A1 (ru) Эмульсия
MXPA06008352A (es) Una composicion farmaceutica.
ATE443515T1 (de) Omega-3-fettsäuren und omega-6-fettsäuren enthaltende zusammensetzung
HK1082758A1 (zh) 在使用抗氧剂的蜡烛中香味的保护
WO2011060945A3 (en) Capsules of active pharmaceutical ingredients and polyunsaturated fatty acid esters for the treatment of cardiovascular diseases
WO2006127083A3 (en) A delivery system for active components as part of an edible composition having selected particle size
MY167583A (en) Infant formula with high sn-2 palmitate and oligofructose
WO2006127070A3 (en) An edible composition including a delivery system for active components
MX2009001156A (es) Composiciones de vitamina d y metodo de administracion a un ser humano.
WO2006127067A3 (en) A delivery system for coated active components as part of an edible composition
MX2009012782A (es) Formulaciones para administracion oral de agentes terapeuticos y metodos relacionados.
WO2008061078A3 (en) Matrix-embedded compositions having organic acids and fatty acids
MX2011007222A (es) Composicion nutricional para infantes.
DE60101859D1 (de) Pinolensäure gegen Diabetes
SE0201566D0 (sv) New composition
WO2002092779A3 (en) Method for enriching tissues in long chain polyunsaturated fatty acids